Literature DB >> 5107027

Levodopa suppression of prolactin in nonpuerperal galactorrhea.

W B Malarkey, L S Jacobs, W H Daughaday.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5107027     DOI: 10.1056/NEJM197111182852102

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  23 in total

Review 1.  Changing concepts of prolactin in man.

Authors:  W P Vander Laan
Journal:  Calif Med       Date:  1973-02

Review 2.  Galactorrhoea.

Authors:  G M Besser; C R Edwards
Journal:  Br Med J       Date:  1972-04-29

3.  The effect of levodopa on galactorrhea in the Forbes-Albright syndrome.

Authors:  M Edmonds; H Friesen
Journal:  Can Med Assoc J       Date:  1972-09-23       Impact factor: 8.262

4.  Inhibition of prolactin and aldosterone secretion by the dopamine derivative ibopamine.

Authors:  E Rolandi; G Marchetti; R Franceschini; V Cicchetti; R Gianrossi; V Cantoni; T Barreca
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

5.  Effect of vitamin B6 on the serum concentration of pituitary hormones in normal humans and under pathologic conditions.

Authors:  M Bigazzi; S Ferraro; R Ronga; G Scarselli; V Bruni; A L Olivotti
Journal:  J Endocrinol Invest       Date:  1979 Apr-Jun       Impact factor: 4.256

6.  Treatment of galactorrhea-amenorrhea syndrome with 2-Br-alpha-ergocryptin (CB 154). Clinical response and pattern of pituitary and steriod hormones before and during therapy.

Authors:  H J Künzig; W Geiger; K D Schulz; K H Lose
Journal:  Arch Gynakol       Date:  1975

7.  Inhibition of thyrotropin and prolactin secretion by dopamine in man.

Authors:  F Massara; F Camanni; V Vergano; L Belforte; G M Molinatti
Journal:  J Endocrinol Invest       Date:  1978-01       Impact factor: 4.256

8.  Galactorrhoea: successful treatment with reduction of plasma prolactin levels by brom-ergocryptine.

Authors:  G M Besser; L Parke; C R Edwards; I A Forsyth; A S McNeilly
Journal:  Br Med J       Date:  1972-09-16

9.  Loss of central nervous system component of dopaminergic inhibition of prolactin secretion in patients with prolactin-secreting pituitary tumors.

Authors:  S A Fine; L A Frohman
Journal:  J Clin Invest       Date:  1978-04       Impact factor: 14.808

10.  Pituitary, thyroid and adrenal responses to clonidine in dairy cattle.

Authors:  R C Gorewit
Journal:  J Endocrinol Invest       Date:  1981 Apr-Jun       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.